卡托普利与硝普钠治疗重症心力衰竭60例临床分析  

Clinical Analysis of Treatments of Captopril and SNP with Severe Heart Failure 60 Patients

作　　者：田峥[1] 

机构地区：[1]大连医科大学附属中山医院,116001

出　　处：《中国医药指南》2010年第36期14-15,共2页Guide of China Medicine

摘　　要：目的研究卡托普利与硝普钠合用治疗重症心力衰竭的临床疗效。方法在大连医科大学附属中山医院2008至2009年重症心力衰竭患者(心功能Ⅳ级)中随机选择60例,并分为观察组(30例)与对照组(30例)。对照组给予洋地黄、利尿剂及ACEI等药物治疗,并纠正病因诱因;治疗组在此基础上加用卡托普利与硝普钠。结果观察组组与对照组用药7d后相比,心功能改善明显,心肌耗氧减少。结论硝普钠与卡托普利合用治疗重症心力衰竭能有效改善心功能,是一个安全而有效的方法 。Objective To study clinical curative effect about the combination therapy of Captopril and SNP to treat severe heart failure.Methods During the 2008-2009 severe heart failure patients（cardiac Ⅳ level） randomly choose 60 cases from Zhongshan Hospital of Dalian Medical University,and divided into the treatment group（30 cases） and control group（30 cases）.The control group gives radix rehmanniae,diuretics and ACEI and other drμgs,and correct pathogeny.The treatment group on this basis,to add a captopril and SNP.Results 7 days later,compare the treatment group with control group heart function was improved,myocardial oxygen consumption was reduced.Conclusion Captopril and SNP can treat effectively for severe heart failure improve cardiac function,was a safe and effective method.

关 键 词：卡托普利 硝普钠 心力衰竭 

分 类 号：R541.6[医药卫生—心血管疾病]